Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study

BACKGROUND: Data on the prevalence of perennial versus seasonal allergic asthma in Italy are lacking; moreover, there is limited evidence on the effect of omalizumab on patient-reported outcomes in Italian patients with severe allergic asthma. PROXIMA, an observational, multicenter study, was design...

Descripción completa

Detalles Bibliográficos
Autores principales: Canonica, Giorgio Walter, Rottoli, Paola, Bucca, Caterina, Zappa, Maria Cristina, Michetti, Giovanni, Macciocchi, Bruno, Caruso, Cristiano, Santus, Pierachille, Bartezaghi, Marta, Rigoni, Laura
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214174/
https://www.ncbi.nlm.nih.gov/pubmed/30410639
http://dx.doi.org/10.1186/s40413-018-0214-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6214174/
https://www.ncbi.nlm.nih.gov/pubmed/30410639
http://dx.doi.org/10.1186/s40413-018-0214-3

Ejemplares similares